Larimar Therapeutics, Inc. — Director's Dealing 2016

Jan 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-01-25

Reporting Person: Barrett Peter (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-25	Common Stock	A	8849	$7.91	Acquired	4643327	Direct

Footnotes

F1: These securities were issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2016 on a quarterly basis in arrears.

F2: The Reporting Person previously reported 5,632,730 shares directly held by Atlas Venture Fund VII, L.P. ("Atlas Venture"). On March 24, 2015, Atlas Venture distributed in-kind 1,000,000 shares pro rata to its limited partners. The Reporting Person now reports 4,632,730 shares directly held by Atlas Venture and disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest, if any, therein.